Clinical Outcomes of Decitabine and the Role of WT-1 Expression as a Surrogate Prognostic Marker for Patients with Elderly Acute Myeloid Leukemia

被引：1
|
作者：
Cho, Byung-Sik [1 ]
Shin, Seung-Hwan [2 ]
Lee, Sung-Eun [1 ]
Park, Sung-Soo [1 ]
Yoon, Jae-Ho [1 ]
Yahng, Seung-Ah [1 ]
Kim, Hee-je [1 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Hematol,Leukemia Res Inst, Seoul, South Korea
[2] Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Hematol, Seoul, South Korea
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
elderly acute myeloid leukemia; decitabine; WT1;
D O I：
10.1016/j.clml.2018.07.049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-123
引用
收藏
页码：S200 / S201
页数：2
相关论文
共 50 条
  • [21] DNA methylation landscape reveals GNAS as a decitabine-responsive marker in patients with acute myeloid leukemia
    He, Shujiao
    Li, Yan
    Wang, Lei
    Li, Yisheng
    Xu, Lu
    Cai, Diya
    Zhou, Jingfeng
    Yu, Li
    NEOPLASIA, 2024, 49
  • [22] The prognostic factors and efficacy of induction chemotherapy in elderly patients with acute myeloid leukemia
    Mao, Jianping
    Gao, Wenliang
    Xue, Lianguo
    Zhao, Lidong
    Miao, Lei
    Jia, Tao
    Zhu, Yuanxin
    Wang, Ying
    Meng, Lijuan
    Wang, Juan
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2020, 10 (06): : 320 - 329
  • [23] Prevalence and clinical characteristics of N-terminally truncated WT1 expression in acute myeloid leukemia
    Ishikawa, Yuichi
    Kiyoi, Hitoshi
    Naoe, Tomoki
    LEUKEMIA RESEARCH, 2011, 35 (05) : 685 - 688
  • [24] Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells
    Krug, Utz
    Yasmeen, Amber
    Beger, Carmela
    Baeumer, Nicole
    Dugas, Martin
    Berdel, Wolfgang E.
    Mueller-Tidow, Carsten
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (01) : 129 - 136
  • [25] High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia
    Luesink, Maaike
    Hollink, Iris H. I. M.
    van der Velden, Vincent H. J.
    Knops, Ruth H. J. N.
    Boezeman, Jan B. M.
    de Haas, Valerie
    Trka, Jan
    Baruchel, Andre
    Reinhardt, Dirk
    van der Reijden, Bert A.
    van den Heuvel-Eibrink, Marry M.
    Zwaan, C. Michel
    Jansen, Joop H.
    BLOOD, 2012, 120 (10) : 2064 - 2075
  • [26] Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis
    He, Pin-Fang
    Zhou, Jing-Dong
    Yao, Dong-Ming
    Ma, Ji-Chun
    Wen, Xiang-Mei
    Zhang, Zhi-Hui
    Lian, Xin-Yue
    Xu, Zi-Jun
    Qian, Jun
    Lin, Jiang
    ONCOTARGET, 2017, 8 (25) : 41498 - 41507
  • [27] Phase 1 dose escalation trial of volasertib in combination with decitabine in patients with acute myeloid leukemia
    Jorge Cortes
    Nikolai Podoltsev
    Hagop Kantarjian
    Gautam Borthakur
    Amer M. Zeidan
    Maximilian Stahl
    Tillmann Taube
    Nora Fagan
    Sushmita Rajeswari
    Geoffrey L. Uy
    International Journal of Hematology, 2021, 113 : 92 - 99
  • [28] Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study
    Bhatnagar, Bhavana
    Zhao, Qiuhong
    Mims, Alice S.
    Vasu, Sumithira
    Behbehani, Gregory K.
    Larkin, Karilyn
    Blachly, James S.
    Blum, William
    Klisovic, Rebecca B.
    Ruppert, Amy S.
    Orwick, Shelley
    Oakes, Christopher
    Ranganathan, Parvathi
    Byrd, John C.
    Walker, Alison R.
    Garzon, Ramiro
    LEUKEMIA & LYMPHOMA, 2020, 61 (02) : 387 - 396
  • [29] Phase 1 dose escalation trial of volasertib in combination with decitabine in patients with acute myeloid leukemia
    Cortes, Jorge
    Podoltsev, Nikolai
    Kantarjian, Hagop
    Borthakur, Gautam
    Zeidan, Amer M.
    Stahl, Maximilian
    Taube, Tillmann
    Fagan, Nora
    Rajeswari, Sushmita
    Uy, Geoffrey L.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (01) : 92 - 99
  • [30] WT1 Expression in Adult Acute Myeloid Leukemia: Assessing its Presence, Magnitude and Temporal Changes as Prognostic Factors
    Ujj, Zsofia
    Buglyo, Gergely
    Udvardy, Miklos
    Beyer, Daniel
    Vargha, Gyoergy
    Biro, Sandor
    Rejto, Laszlo
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (01) : 217 - 221
12345